The SaaS Term Sheet Bible: The Complete Guide for Founders
The complete guide to reading, negotiating, and understanding SaaS term sheets. This guide walks through every material term: liquidation preferences, anti-dilution provisions, board composition, protective provisions, pro-rata rights, drag-along and co-sale mechanics, exclusivity, and the red flags you must recognise. Written for founders navigating seed through Series B, and for any operator who needs to understand exactly what they are signing and why it matters.
How to read a term sheet. The math behind liquidation preferences, anti-dilution, and board control. Which terms to negotiate and which to accept. How to spot red flags. What founder-friendly actually means.
Download the Term Sheet Checklist. Know what to ask before you sign.
Part I: Reading a Term Sheet
Chapter 1: What a Term Sheet Is (and What It Is Not)
A term sheet is a non-binding letter of intent that outlines the key commercial terms of an investment. It is typically 8-15 pages, written in plain English (or as plain as venture documents get), and covers the fundamentals: how much money the investor is putting in, what valuation, what control they get, what rights they retain, and what happens in a sale. It is not a binding contract. It is not the final legal document. It is the negotiation framework on which all downstream legal documents are built.
The timeline from signed term sheet to closing cash typically runs 4-8 weeks. The term sheet kick-starts legal documentation. Your lawyers and the investor's lawyers begin negotiating the stock purchase agreement (the binding contract), investor rights agreement (outlining ongoing rights like board seats and information rights), right of first refusal and co-sale agreement (covering future sales), and various other exhibits. During this legal phase, diligence happens in parallel. Investors validate your financial model, customer contracts, cap table, IP ownership, and other material facts. By the time money wires, you have been through 4-8 weeks of legal drafting, revision, re-revision, and negotiation.
What a term sheet is not: It is not final. It is not binding. It is not a guarantee of funding. A signed term sheet is not the same as money in the bank. I have seen deals signed with a term sheet and walked by an investor weeks later if diligence uncovers problems. A signed term sheet is a serious commitment, but it remains non-binding unless stated otherwise (and most contain explicit carveouts that make certain sections binding, like confidentiality and exclusivity).
Why Term Sheets Matter
Term sheets matter because they establish the economic relationship between you and your investors. They determine how much of the company you own after the investment closes, what happens to your ownership if the business gets sold, what rights investors have to control decisions, and how much dilution you face in future rounds. A founder who signs a bad term sheet can find themselves owning a tiny fraction of a company worth hundreds of millions of pounds. Conversely, a founder who negotiates smart terms can maintain control and upside even as the company grows. The difference between a founder-friendly and investor-friendly term sheet is literally worth millions of pounds.
The Standard Sections of a Term Sheet
Most term sheets follow a standard structure. The first sections cover the basics: investor identity, investment amount, pre-money valuation, post-money valuation, and use of proceeds. Then come the economic terms: liquidation preferences, participation rights, conversion mechanics, and dividends. Then come the control terms: board composition, protective provisions, information rights, and inspection rights. Then come investor rights: pro-rata rights, drag-along and co-sale rights. Then come other terms: exclusivity, no-shop, representations and warranties. Finally, a closing conditions section outlines what has to be true before money wires.
Professional investors use nearly identical term sheet structures. This is deliberate. It allows founders and their lawyers to quickly spot non-standard or unusual terms. If an investor insists on adding or materially changing standard language, that is a red flag. It suggests they are either trying to hide something or testing whether you understand the document. Either way, pushback is warranted.
Chapter 2: Valuation Mechanics (Pre-Money, Post-Money, Option Pool Shuffle)
Understanding how valuation works at the arithmetic level is foundational. Founders who do not understand the maths of pre-money, post-money, and fully diluted shares often end up surprised when they calculate their actual ownership after a round closes.
Pre-money valuation is what the investor says the company is worth before their cheque arrives. If an investor says they will invest £5M at a £20M pre-money valuation, they are saying: the company was worth £20M before this money, and I am putting in £5M for the right to own a chunk of that £20M pre-money company. Post-money valuation is simply the pre-money valuation plus the investment. So £20M pre + £5M investment = £25M post-money. The investor owns £5M / £25M = 20% of the company.
This is counterintuitive to many founders: the investor owns the £5M / (pre + investment), not the investor owns (the pre-money / investment). Because the investor is investing into a pool. After the investment closes, the company is worth £25M, and the investor owns £5M worth of that £25M, which equals 20%.
Common shareholders (usually you, the founders) owned 100% of the company before the investment. After the investment, common shareholders own (£20M / £25M) = 80%. But this number is rarely how you think about it as a founder. Most founders ask: how much of the company do I own? The honest answer is: it depends on how many shares you agreed to issue. The investor is buying shares at whatever price per share is implied by the valuation. If the pre-money is £20M and you have 10 million shares outstanding, each share is worth £2. The investor buys £5M / £2 = 2.5 million shares. New total: 12.5 million shares, of which you own 10 million = 80%.
The Option Pool Shuffle
Here is where it gets tricky. Most venture-backed companies create an employee option pool at the time of investment. The pool is typically 15-20% of the post-money fully diluted shares. If the post-money valuation is £25M and you decide on a £5M pool (20%), that pool is worth £5M in value but represents 5M out of 12.5M new total shares. Wait, 5M + 10M + 2.5M (investor shares) = 17.5M, not 12.5M. So the new total is 17.5M shares.
From the investor's perspective, they bought 2.5M shares out of a post-money total of 17.5M = 14.3%, not 20%. But they negotiated a 20% stake. So what happens? The pre-money and post-money are recalculated to account for the pool as if it were already issued. This is the option pool shuffle. It appears in nearly every term sheet and is standard practice, not nefarious. Just understand what it is doing: it is protecting the investor's percentage by increasing the total share count upfront.
Fully Diluted Shares
Fully diluted shares means: all common shares, plus all preferred shares (investor shares), plus all shares underlying outstanding options. It is the denominator you use to calculate ownership percentages after all potential share issuance. The reason this matters is simple: if you own 5 million common shares out of 20 million fully diluted, you own 25%, even though only 10 million shares are actually issued. Those unissued 10 million are options that could convert to shares when employees exercise them. For purposes of calculating your actual ownership and dilution, you count them.
Chapter 3: Economic Terms Overview
Economic terms determine who gets paid what when the company is sold or liquidated. The four main economic terms are: liquidation preference, participation rights, conversion mechanics, and dividends. Understanding each one is essential because they determine your actual economics in different exit scenarios.
Part II: Economic Terms Deep Dive
Chapter 4: Liquidation Preferences (1x Non-Participating vs 2x Participating)
Liquidation preference determines the order in which proceeds are paid in a liquidation (a sale, bankruptcy, wind-down, etc.). It is one of the most misunderstood and important terms because it directly determines whether you, the founder, get anything from a sale.
The standard founder-friendly term is "1x non-participating preferred." This means: preferred shareholders (investors) get back 1x their investment before common shareholders (you) get anything. Once preferred gets paid, all remaining proceeds go to common in proportion to ownership. A worked example makes this clear.
Imagine a £30M exit. The company has a Series A investor who invested £5M at a £20M pre-money (20% ownership). Under 1x non-participating, the Series A gets their £5M back first. Remaining proceeds: £30M - £5M = £25M go to all shareholders in proportion to their ownership stakes. Series A owns 20%, so they get 20% of £25M = £5M additional. Total for Series A: £10M. Founders own 70%, so they get 70% of £25M = £17.5M. If there are other investors at other preferences, they get paid in order of their preference.
The aggressive alternative is "2x participating preferred." This means investors get 1x their investment back, then they also participate in the remaining proceeds as if they were common shareholders. Under 2x participating in a £30M exit: Series A gets £5M back first. Then they get their 20% of remaining £25M = £5M. Then they get an additional £5M (the second "2x" multiple). Their total is £15M. Founders only get 70% of what remains after the second £5M is allocated to Series A, which is 70% of £20M = £14M. Founders get significantly less.
The threshold where liquidation preference matters is below about £40-50M for a typical Series A. In a £80M exit with 2x participating, the math works out fairly since the 2x cap is hit early and then pro-rata allocation takes over. But below £50M, liquidation preference can be devastating to founder returns. This is why 1x non-participating is standard and 2x participating is a red flag that immediately suggests this investor does not expect significant upside.
The Negotiation Points on Liquidation Preference
Always push for 1x non-participating. It is standard for early-stage rounds (seed through Series A). If an investor insists on 2x participating, it is a signal of distress about the business or about market conditions. Understand why before accepting. If you do accept 2x participating, make sure it is paired with a low pre-money valuation or you are getting something else in return (lower board control, fewer protective provisions, etc.).
Chapter 5: Anti-Dilution Provisions (Broad-Based Weighted Average vs Full Ratchet)
Anti-dilution is the investor's protection if a future funding round occurs at a lower valuation (a down round). If you raise a Series A at £20M pre, then later raise a Series B at £10M pre, existing Series A investors are protected from having their effective purchase price increase. Anti-dilution adjusts their conversion price downward so they own more shares at the lower valuation.
The two main types are broad-based weighted average and full ratchet. Broad-based weighted average is founder-friendly and standard. Full ratchet is toxic for founders. The formula for broad-based weighted average is complex but the intuition is: your effective price per share gets adjusted based on the dollar-weighted average of all the shares issued at different prices. A worked example:
Imagine a Series A raised £5M at £20M pre (valuation £4 per share, on 5M shares). A year later, Series B raises £4M at £10M pre (valuation £2 per share). Under broad-based weighted average, the Series A conversion price is adjusted. New calculation: total pre-money is now £10M, total Series A investment is £5M. The broad-based adjustment means the Series A's conversion price is lowered to account for the fact that later money came in at a lower price. The new price is roughly: (5M original shares * £4 + 4M new shares * £2) / 9M total shares = approximately £3.11 per share. Series A gets additional shares to compensate.
Full ratchet is brutal. It says: if a down round occurs, investors' conversion price resets to the down-round price. So if Series A invested at £4 per share and Series B comes in at £2 per share, Series A's conversion price becomes £2 per share as if they had invested at the down round. This massively dilutes founders because Series A now owns 2.5x more shares (£5M / £2 vs £5M / £4). Founders are diluted 2.5x for something they had nothing to do with.
Always negotiate for broad-based weighted average. Full ratchet is almost never acceptable. If an investor insists on full ratchet, it means they expect a down round or are pricing in high execution risk. Push back hard. If they will not budge, walk if you have other options. A full ratchet in your seed round will haunt you through Series B.
Chapter 6: Dividends and PIK
Dividends are a rare but important term. Most venture-backed companies do not pay dividends; all cash is reinvested into growth. But in some term sheets (particularly in late-stage rounds or when investors are worried about returns), a dividend or "PIK" (paid-in-kind) dividend appears.
A cumulative 8% PIK dividend means investors earn 8% per year on their investment, compounding, even if the company never pays out cash. After 5 years, that 8% compound dividend effectively multiplies the investor's investment by 1.47x (1.08^5). For a £5M investment, that is £7.35M owed before any sale proceeds are divided. This dramatically reduces founder upside in a sale.
Non-cumulative dividends are slightly better for founders because they do not compound, only accrue yearly. But they are still problematic. A non-cumulative 8% dividend on £5M is £400k per year that reduces proceeds available to founders. Cumulative dividends are red flags and should be resisted unless you are getting an exceptional valuation in return.
Chapter 7: Board Composition and Control Evolution
Board control is critical because it determines who has a vote on major decisions. As you raise capital, the board evolves. At pre-seed, it might be just you and a co-founder. Post-seed, it is often 2 founders + 1 investor = 3 person board. Post-Series A, it is typically 2 founders + 2 investors + 1 mutual agreed upon independent director = 5 person board. Post-Series B, it often becomes 2 founders + 2-3 investors + 1-2 independents = 5-6 person board or larger.
The key insight: You do not need board majority to control decisions, as long as you have protective provisions (veto rights on major decisions). Many founders lose their board majority at Series B and panic. But with smart protective provisions, you can maintain effective control over the decisions that matter: hiring/firing executives, raising new rounds, selling the company, changing the business fundamentally, etc.
Board Composition Negotiation
In early rounds (seed), push for founders to control the board. You typically get 2 seats and the investor gets 1 seat. If the investor pushes for a board seat for themselves plus the right to appoint another seat, that is aggressive and worth negotiating. In Series A, the 2F+2I+1 mutual structure is standard and acceptable. In Series B and beyond, you may lose majority, but protective provisions matter more than board majority.
Chapter 8: Protective Provisions (The Investor Veto List)
Protective provisions are a list of major decisions that require investor consent even if the board votes otherwise. Standard protective provisions include: amendment to the articles of incorporation, change to the authorized shares or preferred share terms, liquidation or sale of the company, acquisition of another company, material change to the business, hiring/firing of the CEO, merger, incurring debt above a threshold, declaring dividends, or repurchasing shares. Most investors' standard protective provisions list 10-15 items.
This is non-negotiable to investors. If you have investors, they are getting protective provisions. The question is whether the list is reasonable or bloated. A reasonable list covers major strategic decisions. An unreasonable list tries to give investors control over day-to-day operations (eg. "any purchase above £100k requires consent" is unreasonable for a £50M ARR company).
When reviewing protective provisions, push back on: items that are too granular (spending thresholds that are unrealistic for your scale), items that vest control over ordinary business decisions (like hiring below C-level), and items that effectively give investors veto over your fundraising strategy (eg. "any fundraise below X valuation requires consent"). These are legitimate negotiation points.
Chapter 9: Information Rights and Inspection Rights
Information rights require you to provide investors with regular financial statements, including P&L, balance sheet, and cash flow. Inspection rights give investors the right to inspect company books and records. These are standard, founder-friendly in reasonable forms, and something you should accept without much pushback.
Reasonable information rights include: quarterly financial statements (typically within 30 days of quarter end), annual audited financials, quarterly or monthly management accounts showing revenue, customer metrics, and burn. Inspection rights typically allow investors to inspect books with reasonable notice, not on a whim.
Red flags: if an investor requires weekly reporting, or requires management accounts within 7 days of month-end (unreasonable for most founders), or reserves the right to inspect at any time without notice, push back. These are burdensome and signal an investor who does not trust your management.
Chapter 10: Pro-Rata Rights (The Right to Follow in Future Rounds)
Pro-rata rights give investors the right to participate in future funding rounds in proportion to their ownership stake. If an investor owns 20% and you raise a Series B, they have the right to buy 20% of the new round to maintain their ownership. This protects them from dilution but can complicate future fundraising.
Most pro-rata rights are granted to "major investors" (typically those investing above £500k or owning above some threshold like 2-5% of the company). This prevents every small seed investor from having pro-rata rights, which would make later fundraising chaotic.
The negotiation point: If an investor is investing £1M, they probably get pro-rata rights. If they are investing £100k, you push back and say pro-rata starts at investors above £500k in total capital. This is reasonable and founders do this regularly.
Chapter 11: Drag-Along and Co-Sale Rights
Drag-along rights force minority shareholders to sell their shares if the majority decides to sell the company. Co-sale rights (right of first refusal) allow minority shareholders to participate in any sale at the same terms as the founder selling. These are different concepts that often appear together.
Drag-along: If you (founders, 60% ownership) and Series A investors (30%) agree to sell the company for £80M, the Series B investor (10%) cannot block it. The drag-along forces them to sell their stake at the agreed price. This is founder-friendly because it removes minority veto power over sales.
Co-sale: If you, the founder, decide to sell your personal stake to another investor, co-sale holders get the right to sell their stake on the same terms. This prevents you from selling your shares without giving investors the same opportunity. This is investor-friendly and reasonable.
Both are standard and should be accepted without significant pushback.
Chapter 12: Exclusivity and No-Shop
Exclusivity typically lasts 30-45 days and requires you not to shop the deal to other investors during that period. You are exclusive with this investor. Violating exclusivity (continuing fundraising from other VCs) can result in the investor walking.
This is a negotiation point. Push for 30 days instead of 45, and push for explicit carveouts (you can continue conversations with investors you are already talking to, even if they are not your lead). Many investors will agree to these carveouts because they understand the reality of fundraising. If an investor insists on strict 45-day exclusivity with no carveouts, that is a minor red flag suggesting they are not confident in their diligence.
Part III: Red Flags and How to Negotiate
Chapter 13: Term Sheet Red Flags and Negotiation Tactics
The following combination of terms should immediately trigger scrutiny. A single term might be acceptable, but combinations signal trouble.
Red Flag 1: 2x or higher participating liquidation preference combined with full ratchet anti-dilution. This combination is devastating to founders in down rounds or moderate exits. If the term sheet includes both, walk unless the pre-money is exceptionally low or you have other offers.
Red Flag 2: Cumulative dividends (especially 8%+ PIK). This investor is pricing in downside risk. In a £30M exit with £5M Series A having 8% cumulative PIK over 5 years, investors owe £7.35M before any pro-rata allocation. Founders are left with pennies.
Red Flag 3: Super-majority protective provisions or board composition. If the investor insists on approval for decisions that should be board-level (CEO hiring, basic fundraising, etc.), or if board composition is skewed toward investors (3I+2F instead of 2I+2F), the investor expects conflict.
Red Flag 4: Extremely short no-shop or no exclusivity at all. If an investor refuses any exclusivity period and reserves the right to walk within 24 hours, they are not committed. Reasonable investors accept 30 days of exclusivity.
Red Flag 5: Information rights that are unreasonably frequent or burdensome. Weekly reporting, financial statements due 7 days after month-end, inspection rights without notice: these signal an investor who does not trust you.
Red Flag 6: Redemption rights (the right to force the company to buy back their shares). This is extremely rare in early-stage VC but appears occasionally and is a massive red flag. It creates a liability on your balance sheet for the investor's stake.
Red Flag 7: Right to appoint multiple board seats, or board veto over fundraising. If the investor insists on appointing 2 board seats (instead of 1) or reserves the right to veto future fundraising, they are building in control disproportionate to their ownership.
How to Negotiate Without Blowing Up the Deal
The key to negotiation is: pick your battles. You cannot win on every term. Professional investors expect founders to negotiate. They do not expect you to roll over. What they do respect is smart, data-backed pushback focused on a few key terms.
Start with valuation. If the pre-money valuation is where you want it, defending other terms is easier. If the valuation is low, the economics are already difficult, and you should consider walking or getting other offers before accepting other unfavourable terms.
Protect the terms that matter most: liquidation preference, anti-dilution, board control. These are worth fighting for. 1x non-participating and broad-based weighted average are standard and founder-friendly. If an investor pushes for 2x participating or full ratchet, that is a meaningful fight.
Use multiple offers as leverage. If you have another offer on better terms, that is powerful negotiating leverage. Use it. Most investors will adjust terms to stay competitive. If they will not, you have a decision to make.
Work with a lawyer. This is not the time to be penny-wise and pound-foolish. Hire a startup lawyer who has seen hundreds of term sheets. They will identify red flags, model economics under different scenarios, and coach you through negotiations. The cost (typically £5-10k) is trivial compared to the upside of getting better terms.
Frame pushback professionally. Do not say "this is unfair" or "I do not like this term." Instead, say: "Based on market standards for Series A rounds, 1x non-participating is typical. Can we get aligned on that?" Or: "Full ratchet anti-dilution is uncommon for early-stage rounds. Have you considered broad-based weighted average instead?" This positions pushback as a market/standard conversation, not personal.
Know which terms to accept without fighting. Drag-along, co-sale, information rights, inspection rights, pro-rata rights (for major investors): these are standard. Accepting them does not hurt you. Do not waste political capital fighting these. Fight liquidation preference, anti-dilution, board control, and protective provisions.
Understand what the investor cares about. If an investor is insisting on a particular term, understand why. Are they protecting against downside? Are they trying to maintain control? Are they following their fund's standard playbook? Understanding motivation helps you find creative solutions. Maybe instead of fighting 2x participating, you accept it but get a lower pre-money valuation or a protective provision carve-out.
The Math That Matters
Always model the economics under multiple scenarios. Model a pessimistic exit (£20M), a base case exit (£50M), and an optimistic exit (£150M). Calculate your founder proceeds under your current draft term sheet in each scenario. Does the math work for you? Are you comfortable with the upside and downside? Are there red flags in specific scenarios? For example, 1x non-participating is friendly at £50M+ but could be devastating if someone has a large PIK dividend. Model it. Know the numbers before negotiating.
Term sheets are fundamental. They determine your economics, your control, and your relationship with investors for years to come. Spend time understanding them. Negotiate thoughtfully. Get legal help. The effort pays off many times over.